Does The Joint Commission require specific elements for titration orders when such orders are permitted by an organization and what other quality or safety advances should be considered ?

Any examples are for illustrative purposes only.

Titration orders are generally defined as those in which the medication dose is either progressively increased or decreased in response to the patient's status. Organizations are required to define, by policy, if titration orders are deemed acceptable for use.  The elements of performance found in the Medication Management (MM) chapter at MM.04.01.01 outline the policy requirements.
 

• Medication name
• Medication route
• Initial or starting rate of infusion (dose/min)
• Incremental units the rate can be increased or decreased
• Frequency for incremental doses (how often dose(rate) can be increased or decreased
• Maximum rate (dose) of infusion
• Objective clinical endpoint (RASS score, CAM score, etc). NOTE: This particular element does not have to reside in the titration order itself but instead may be a separate order in the medical record.

• Initial or starting rate of infusion (dose/min) 
• Incremental units the rate can be increased or decreased
• Frequency for incremental doses (how often dose(rate) can be increased or decreased
• Objective clinical endpoint(RASS score, CAM score, etc).

• Compliance with manufacturer's Instructions For Use (IFU) for safe administration
• Consistent administration practices among nurses and other practitioners
• Ensure the patient response is achieved/sustained
• Nursing not placed in a position of making dosing/administration decisions that may conflict with their scope of practice
• Documentation accurately reflects order changes, patient assessments, etc.